Services NST provided to Astex Pharmaceuticals included medical writing for:
"The NST teams we worked with delivered high-quality work, including clinical protocols, clinical study report and narrative writing along with performing Quality Reviews of our documents, allowing us to overcome our regulatory hurdles without losing pace on other projects. Importantly, their unique approach to preparing these documents generated outstanding products with only reasonable input from us and minimal revisions – a welcome contrast to other similar firms we had worked with in the past."
An important part of Astex’s portfolio is the development of hypomethylating agents for treatment of various diseases, including myelodysplastic syndromes and acute myeloid leukemia. NST was a drug development partner on Astex’s business-critical regulatory writing projects. Projects included clinical protocols, protocol amendments, clinical study reports and safety narratives. The NST team generated high-quality deliverables, largely autonomously, while simplifying complex concepts, drawing on their vast regulatory expertise. NST’s involvement provided valuable writing capacity when Astex’s in-house teams were fully occupied, enabling greater operational efficiency. NST endeavours made an invaluable contribution to Astex’s clinical pipeline.
At the height of the pandemic, Niche's rapid manuscript writing helped Synairgen publish their landmark interferon beta.
read moreNiche built and coordinated the full communications strategy for this 20-institution European initiative, turning.
read morePutting patients first, Niche supported ViiV Healthcare's global HIV outreach programmes with medical writing,.
read moreWhen stalled regulatory documentation threatened to derail their neurological programme, Cleothena turned to Niche —.
read moreNiche delivered rigorous QC and medical writing support across Adaptimmune's full suite of regulatory documents, keeping.
read moreOver a decade and 20+ guidelines later, Niche remains the BSH's trusted partner for raising haematology care standards.
read moreFrom Phase 2 through to the global Phase 3 HEAL-MI trial, Niche has been Recardio's trusted writing and regulatory.
read moreNiche supported Nabriva's antibiotic lefamulin from early clinical protocols all the way to FDA, EMA and Health Canada.
read moreFor over a decade, Assign DMB relied on Niche as their embedded writing partner, seamlessly converting statistical.
read moreA trusted writing partner to this Belfast-based early-phase CRO for over a decade, Niche turned BioKinetic Europe's.
read moreNiche served as the English-language regulatory writing backbone for this Nordic consultancy, producing IBs, IMPDs and.
read moreGet our latest news and publications
Sign up to our news letterResources
Social
Contact us
Address
Niche Science & Technology
Unit 26 Falstaff House
Bardolph Road
Richmond TW9 2LH
United Kingdom
